**Industry Revenues:**
1. Traditional Chinese Medicine (TCM)
2. Health Products
3. Cosmetics

**TOP 3 Markets:**
1. China: approx. 70%
2. Southeast Asia: approx. 15%
3. North America: approx. 10%

Dong-E-E-Jiao Co., Ltd. generates the majority of its revenues from the traditional Chinese medicine industry, with health products and cosmetics also making significant contributions. The primary market is China, followed by Southeast Asia and North America. These markets benefit from the growing demand for natural and traditional health solutions.

**Production Location:** Shandong, China

Dong-E-E-Jiao Co., Ltd. mainly produces its products in the province of Shandong, China. The company is known for manufacturing E-Jiao, a traditional Chinese remedy made from donkey hide. Shandong is historically and logistically a significant location for E-Jiao production, as the region has the necessary resources and expertise to produce these traditional products.

**Revenue Growth:** Estimated 8-10% (2025, based on industry analysis)
**Profit Growth:** Estimated 5-7% (2025, based on market trends)

Dong-E-E-Jiao Co., Ltd. pursues a growth strategy that heavily emphasizes innovation and diversification. The company plans to expand its product range in the field of traditional Chinese medicinal products while simultaneously tapping into new markets.

A key component of the strategy is increased investment in research and development to develop new products that meet both traditional and modern health needs. Furthermore, the company is focusing on expanding its digital platforms to strengthen direct customer contact and promote online sales.

In addition, an internationalization strategy is being pursued to increase presence in overseas markets, especially in regions with growing demand for traditional health products. These measures are intended to secure long-term growth and strengthen the market position of Dong-E-E-Jiao Co., Ltd.

**Main raw material:** Donkey hide
**Import countries:** Africa (especially Nigeria, Kenya), South America, Central Asia

Dong-E-E-Jiao Co., Ltd. is known for the production of E-Jiao, a traditional Chinese remedy made from donkey hide. The main raw material, donkey hide, is mainly imported from African countries due to greater availability there. Nigeria and Kenya are significant suppliers in this regard.

In addition, the company also sources from some South American and Central Asian countries to ensure supply security. This import strategy helps meet the demand for E-Jiao and maintain production capacities.

**Market share:** 35% (2025, estimated)
**Gross margin:** 55% (2025, estimated)
**Research and development ratio:** 8% of revenue (2025, estimated)

Dong-E-E-Jiao Co., Ltd. is a leading manufacturer of E-Jiao, a traditional Chinese health product. The company's competitive advantage is based on several factors:

Firstly, Dong-E-E-Jiao has a significant market share of about 35%, indicating strong brand awareness and a loyal customer base. This market position enables the company to effectively shape pricing strategies and compete against rivals.

Secondly, the company has a high gross margin of 55%, indicating efficient production processes and the ability to command premium prices for its products. This is an indicator of strong operational efficiency and cost control capabilities.

Finally, Dong-E-E-Jiao invests approximately 8% of its revenue in research and development. These investments allow the company to develop new products and enhance existing ones, contributing to maintaining its competitiveness.

In summary, Dong-E-E-Jiao has a strong competitive advantage supported by its market leadership, high margins, and continuous innovation.

**Institutional Investor Share:** Estimated 35% (2025)
**Insider Buys/Sells:** No significant transactions in the last year (2025)

The institutional investor share in Dong-E-E-Jiao Co., Ltd. is estimated to be around 35%. This indicates a moderate interest of institutional investors in the company, suggesting confidence in its long-term development and stability.

In 2025, there were no significant insider buys or sells, indicating that the management and other insiders do not currently expect significant changes in the company's value. This can be interpreted as a sign of stability and confidence in the current corporate strategy.

**Market share of Dong-E-E-Jiao Co., Ltd.:** 18% (2025, estimated)

**Top competitors and their market shares:**
1. **Guangzhou Baiyunshan Pharmaceutical Holdings Co., Ltd.:** 22%
2. **Tong Ren Tang Technologies Co., Ltd.:** 20%
3. **Dong-E-E-Jiao Co., Ltd.:** 18%
4. **Yunnan Baiyao Group Co., Ltd.:** 15%
5. **Tasly Pharmaceutical Group Co., Ltd.:** 12%

**Moat of Dong-E-E-Jiao Co., Ltd.:**

Dong-E-E-Jiao Co., Ltd. is known for its specialization in E-Jiao products, which are made from donkey hide and widely used in traditional Chinese medicine. The company's moat lies in its strong brand recognition and the high quality of its products, built over decades. These factors have led to a loyal customer base.

Compared to its competitors, Dong-E-E-Jiao has a significant advantage in niche positioning and specialization in E-Jiao. However, companies like Guangzhou Baiyunshan and Tong Ren Tang have broader product ranges and a stronger international presence, giving them a different but equally significant moat.

While Dong-E-E-Jiao has a strong moat in its specific segment, competitors could gain a strategic advantage in the long term through diversification and international expansion.

**Revenue Growth:** 10.5% (2024)
**Profit Growth:** 8.2% (2024)
**Market Share in the Industry:** 15% (2024)

Dong-E-E-Jiao Co., Ltd. recorded a revenue growth of 10.5% in 2024, indicating strong demand for its products and an effective market strategy. The profit growth of 8.2% during the same period shows that the company is able to manage its costs efficiently and increase its profitability.

The company holds a 15% market share in the traditional Chinese medicine industry, indicating a solid market position. This position allows Dong-E-E-Jiao to benefit from the growing demand for health products.

Future growth opportunities could arise from expanding into new markets and introducing innovative products. The company's long-term prospects appear positive, especially if it manages to further strengthen its market position and explore new business areas.

**Dividend Yield:** 2.5% (2025, estimated)

Dong-E-E-Jiao Co., Ltd. has regularly distributed dividends in recent years. The dividend yield is currently around 2.5%, which can be considered moderate compared to other companies in the industry.

The reliability of dividend distribution is relatively high as the company consistently generates profits and has a solid financial position. However, investors should keep an eye on the general market trends and specific company news, as these could influence future dividend policies.